CardioAge, SoLongevity’s new nutraceutical
From SoLongevity research comes CardioAge, a next-generation supplement developed to provide metabolic support for circulatory health, particularly suitable for those with risk factors for heart attack and stroke, and generally for all cardio- and neurovascular diseases.
What is homocysteine?
We all know the classic factors that put the heart and blood vessels at risk, such as having hyperglycemia or diabetes, high blood pressure, hypercholesterolemia, being overweight and obese, having a family history of these conditions, or having had previous heart attacks and strokes. And we also know about unhealthy lifestyles, such as sedentary lifestyle and smoking habits. Less well known is another risk factor: the presence of high levels of homocysteine (hyperhomocysteinemia), an amino acid, in the blood.
“Hyperhomocysteinemia is a little-known cardio- and neurovascular risk factor. It is detected by a simple blood test and can help the physician get a better picture of the individual’s risk for stroke, heart attack, and vascular disease.”
Hyperhomocysteinemia has a negative effect on the health of the vascular system because it promotes the processes of atherosclerosis: it alters both directly and indirectly the structure of the vessels and the functions of the endothelium lining them. The Are various causes of hyperhomocysteinemia: enzyme defects, diseases (hypothyroidism, renal failure, tumors, and a rare disease called homocystinuria), nutritional deficiencies, and side effects of drugs. In addition, 10 to 15 percent of the Italian population (about 20 percent in the South), have variants in the gene coding for 5-mtfh reductase that can promote this condition.
How does CardioAge work?
Based on the evidence, after three years of research and development and the publication of a study in the prestigious scientific journal NutrientsSoLongevity has developed CardioAge, which helps regularize homocysteine levels by converting it into endogenous glutathione , one of the most powerful antioxidants in our bodies, and into a source of methyls.. But that’s not all: CardioAge helps prevent or delay the onset of aging-related conditions and helps regularize the biochemical processes that lead to the synthesis of many substances useful for cell physiology and, consequently, for overall health. Its formulation is designed to ensure high bioavailability.
“CardioAge contributes to the control of homocysteine levels, protecting blood vessels. It also contributes to normal cell energy metabolism, helping to reduce fatigue and tiredness by providing riboflavin (Vit. B2) and niacin (Vit. B3). Finally, it promotes the endogenous production of glutathione, also providing vitamin B6 and folate, both directly and indirectly.”
Who is CardioAge suitable for?
CardioAge is indicated for all people with cardio- and neurovascular risk factors, especially those with elevated homocysteine levels. It is also recommended for individuals who are folate deficient, that is, who have insufficient levels of methylation, due to chronic conditions (such as hypothyroidism) or due to the consumption of medications (e.g., contraceptives) or due to a diet where the “green” component is absent or very low. It can also be used to support the maintenance of good cardiovascular and metabolic health above age 45, particularly if one has a “pro-oxidant” lifestyle, in menopausal women (when cardiovascular risk increases due to hormonal changes), and in those with age-related neurocognitive disorders.
“CardioAge regulates homocysteine, is an antioxidant booster and a source of methyls.”